Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

p53 Mutation and MDM2 amplification in inflammatory myofibroblastic tumours.

Histopathology - 1 May 2003

Yamamoto H, Oda Y, Saito T, Sakamoto A, Miyajima K, Tamiya S, Tsuneyoshi M

Abstract excerpt

AIMS: The pathogenic mechanism and predictive indicators of biological behaviour of inflammatory myofibroblastic tumour are poorly understood. We investigated molecular abnormalities of p53 and MDM2 in order to assess whether these play an important role in pathogenesis, and whether they also con...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Immunoenzyme Techniques
Share to Microfilament Proteins
Share to Anaplastic Lymphoma Kinase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Calcium-Binding Proteins

Share to Calmodulin-Binding Proteins

Share to Calponins

Share to Proto-Oncogene Proteins c-mdm2

Share to Receptor Protein-Tyrosine Kinases

Source

Identifiers

PMID: 12713619
DOI: 10.1046/j.1365-2559.2003.01611.x

Genes

MDM2
ALK

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-12713619-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

p53 Mutation and MDM2 amplification in inflammatory myofibroblastic tumours.PMID 12713619Read ↗

Inflammatory myofibroblastic tumor with predominant anaplastic lymphoma kinase-positive cells lacking a myofibroblastic phenotype.Semantic proximity Read ↗

ALK-Negative Lung Inflammatory Myofibroblastic Tumor in a Young Adult: a Case Report and Literature Review of Molecular AlterationsSemantic proximity Read ↗

Inflammatory myofibroblastic tumor with RANBP2 and ALK gene rearrangement: a report of two cases and literature review.Semantic proximity Read ↗

TPM3-ALK and TPM4-ALK Oncogenes in Inflammatory Myofibroblastic TumorsSemantic proximity Read ↗

A novel TPD52L2-ROS1 gene fusion expanding the molecular alterations in inflammatory myofibroblastic tumor: case report and literature reviewSemantic proximity Read ↗

Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor.Semantic proximity Read ↗

Misdiagnosis of inflammatory myofibroblastic tumor as primary pulmonary myxoid sarcoma: A case reportSemantic proximity Read ↗

Comparison of morphological, immunohistochemical, and molecular genetic features of inflammatory fibroid polyps (Vanek's tumors).Semantic proximity Read ↗

A Case Report of RRBP1-ALK Fusion Gene-Positive Epithelioid Inflammatory Myofibroblastic Sarcoma With Collagenous StromaSemantic proximity Read ↗

Inflammatory Myofibroblastic Tumor in the Inguinal canal: A Rare Case ReportSemantic proximity Read ↗

Crizotinib combined with bronchoscopic interventional treatment in ALK-positive Inflammatory myofibroblastic tumor of left main stem bronchus: a case reportSemantic proximity Read ↗

Inflammatory malignant fibrous histiocytomas and dedifferentiated liposarcomas: histological review, genomic profile, and <i>MDM2</i> and <i>CDK4</i> status favour a single entitySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.